ScreenerHero
STRAPStrategic Partners A/S
CPH · DK · Healthcare · Biotechnology · strategic-partners.dk
700.00DKK+2.94%Mkt Cap: 5.48M $P/E: 22.57

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 202…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap5.48M $
Enterprise Value1.72M $
Revenue (TTM)44.28K $
Gross Profit44.28K $
Net Income (TTM)-125.12K $
Revenue/Share1.061 USD
Last Price700.00 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryDK
SectorHealthcare
IndustryBiotechnology
ISINDK0062502894
Valuation
P/E (Trailing)22.57
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue38.93
P/S120.23
P/B1.54
EPS (TTM)30.98
EPS (Forward)—
52W Range
515.0032% of range1100.00
52W High1100.00 DKK
52W Low515.00 DKK
Profitability
Gross Margin100.00%
Oper. Margin-927.00%
EBITDA Margin0.00%
Profit Margin-277.99%
ROE-4.67%
ROA-4.40%
Growth
Revenue Growth-4.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-311.11K $
CapEx (TTM)—
FCF Margin-410.44%
FCF Yield-3.32%
Net Debt-2.41M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio23.55
Quick Ratio23.55
Book Value/Sh440.88 DKK
Cash/Share396.24 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateDec 6, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.53.75K
Float16.78K
Insiders68.93%
Institutions4.52%
Technical
SMA 50637.10 (+9.9%)
SMA 200651.72 (+7.4%)
Beta0.28
S&P 52W Chg18.16%
Avg Vol (30d)65
Avg Vol (10d)71
Technical Indicators
RSI (14)48.9
MACD16.8535
MACD Signal24.7224
MACD Hist.-7.8689
BB Upper774.88 DKK
BB Middle714.75 DKK
BB Lower654.62 DKK
BB Width16.83%
ATR (14)43.48 DKK
Vol Ratio (20d)0.23x